TRPC1 and breast cancer: An epirubicin-resistant BC MCF-7 cell line (MCF-7/EPI) was established, and MCF-7/EPI cells showed significantly lower EPDR1 levels and TRPC1 levels and remarkably higher PI3K and p-AKT protein expression levels compared to parental cells (Fig. 5E).